The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...

The Ozempic maker’s controlling shareholder intends to replace seven directors, including the Denmark-based company’s ...

Novo Nordisk and Eli Lilly stocks slumped Friday after President Donald Trump said he would cut the price of weight-loss ...

Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...

Novo Nordisk’s consensus analyst price target has recently experienced a slight adjustment, moving down from DKK 444.05 to DKK 438.59. This change comes amid a blend of optimism and caution, ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The changing of the guard at Novo Nordisk took another turn this week as the company revealed that seven members of its board ...